Skip to content

Abstract 6765: Lipid Management Patterns and Low-Density Lipoprotein Cholesterol Goal Attainment Among Patients with High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke in the US Stratified by Race/Ethnicity

Nov 2026 · Circulation · 0 citations

Abstract

Background: Prior studies demonstrate persistent race and ethnic disparities in lipid-lowering therapy (LLT) utilization among patients with prior ischemic events. These disparities may be more pronounced in a high cardiovascular (CV) risk population without prior myocardial infarction (MI) or stroke where patients are perceived to be at a lower risk. Nevertheless, real-world lipid management in different racial and ethnic groups for this high CV risk population without prior MI or stroke remains poorly characterized. Research question: Are there race/ethnicity differences in lipid management patterns and low-density lipoprotein cholesterol (LDL-C) goal achievement among patients at high CV risk without prior MI or stroke in the US? Methods: Patients meeting high CV risk criteria (ie, aged ≥ 50 years with documented coronary artery disease [CAD], atherosclerotic cerebrovascular disease [CeVD], peripheral artery disease [PAD], or high-risk diabetes mellitus [HRDM] and elevated lipids, and additional CV risk factors) but no history of MI or stroke were selected from de-identified US Optum Market Clarity electronic health record-linked claims (2016-2025). The earliest date when all criteria were met was defined as the index. Results are summarized by race/ethnicity for index LLT use, LLT intensification over 1 year of follow-up, and LDL-C goal achievement (< 70 mg/dL and < 55 mg/dL). Results: Of 1,351,860 patients, 913,995 were non-Hispanic (NH)-White; 154,252 were NH-Black, 118,787 were Hispanic; and 46,323 were Asian. CAD and CeVD were more common in NH-White patients, and PAD and HRDM were higher in NH-Black and Hispanic patients, as compared to other race/ethnic groups ( Table ). Across all groups, statin monotherapy was the most common LLT at index (~50%), and combination therapy use was < 3%; whereas 51.6% of NH-Black, 46.1% of NH-White, 45.9% of Hispanic, and 40.5% of Asian patients had no LLT use. LLT initiation within 1-year post-index was 42.0% (NH-White), 45.2% (NH-Black), 49.6% (Hispanic), and 49.3% (Asian). Among patients on LLT at index, LLT intensification was approximately 11% across all groups. LDL-C testing within 1-year post-index occurred in 75.4% of NH-White, 73.4% of NH-Black, 81.3% of Hispanic, and 80.2% of Asian patients. Among patients with LDL-C values (n = 404,422), 27.5% of NH-White, 19.5% of NH-Black, 24.8% of Hispanic, and 28.9% of Asian patients achieved LDL-C < 70 mg/dL; 11.5%, 7.4%, 10.3%, and 12.4%, respectively, achieved LDL-C < 55 mg/dL. Conclusions: Across all racial and ethnic groups, patients underutilized LLT and infrequently achieved LDL-C targets. NH-Black patients had the lowest proportion of LDL-C goal attainment despite similar follow-up lipid testing, potentially due to baseline differences. These findings highlight the need for targeted strategies to optimize LLT and ensure equitable LDL-C goal attainment across diverse populations.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.